JEST
PRCT icon

JTC Employer Solutions Trustee’s Procept Biorobotics PRCT Stock Holding History

JTC Employer Solutions Trustee’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20K Hold
810
– – ﹤0.01% 271
2025
Q4 		$25K Hold
810
– – ﹤0.01% 270
2025
Q3 		$30K Buy
+810
New +$37K ﹤0.01% 263

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JTC Employer Solutions Trustee's PRCT Position: Q1 2026 in Review

JTC Employer Solutions Trustee held its Procept Biorobotics (PRCT) position steady in Q1 2026 at 810 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #271.

JTC Employer Solutions Trustee first reported a position in PRCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $30K in Q3 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • JTC Employer Solutions Trustee held 810 shares of Procept Biorobotics worth $20K as of Q1 2026.
  • JTC Employer Solutions Trustee left its Procept Biorobotics share count unchanged in Q1 2026.
  • Procept Biorobotics made up ﹤0.01% of JTC Employer Solutions Trustee's portfolio in Q1 2026, its #271 holding.
  • JTC Employer Solutions Trustee first reported a position in Procept Biorobotics in Q3 2025 and has held it in 3 quarters since.
  • JTC Employer Solutions Trustee's Procept Biorobotics position peaked at $30K in Q3 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q1 2026, filed 19 May 2026.